KCM
MDT icon

Karp Capital Management’s Medtronic MDT Stock Holding History

Karp Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-505
Closed -$46K – 271
2018
Q4 		$46K Buy
+505
New +$47.2K 0.02% 147
2015
Q4 		– Sell
-1,570
Closed -$105K – 215
2015
Q3 		$105K Buy
1,570
+1,002
+176% +$73.8K 0.07% 125
2015
Q2 		$42K Buy
568
+107
+23% +$8.18K 0.03% 181
2015
Q1 		$36K Buy
461
+2
+0.4% +$152 0.02% 198
2014
Q4 		$33K Buy
+459
New +$31.9K 0.02% 187

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Karp Capital Management's MDT Position: Q1 2019 in Review

Karp Capital Management sold out of Medtronic (MDT) in Q1 2019, closing a stake of 505 shares — an estimated $46K sold.

Karp Capital Management first reported a position in MDT in Q4 2014 and held it in 5 quarters. The position peaked at $105K in Q3 2015. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • Karp Capital Management reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
  • Karp Capital Management sold 505 Medtronic shares in Q1 2019, an estimated $46K.
  • Karp Capital Management first reported a position in Medtronic in Q4 2014 and held it in 5 quarters.
  • Karp Capital Management's Medtronic position peaked at $105K in Q3 2015.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on Karp Capital Management's 13F filing for Q1 2019, filed 7 May 2019.